Collectively, our study elucidates a novel mechanism by which ARID1A loss contributes to the development of pancreatic cancer and clarify the distinct features in the microenvironment of pancreatic tumours with different genetic alterations. This evidence concerns the gene ARID1A and familial pancreatic carcinoma.